Health Jun 07

Watch 6:00
Why the FDA approved a controversial Alzheimer’s drug

The FDA on Monday approved the first new drug to treat Alzheimer's disease in nearly two decades. Federal health officials said it may help slow the brain-destroying disease's progression, but the approval goes against the agency's independent advisers who said…

With businesses shuttering, professional sports leagues suspending their seasons and widespread travel restrictions initiated around the world, the economic fallout from the new coronavirus outbreak may continue for months. Vijay Vaitheeswaran, U.S.business editor for The Economist, joins Hari Sreenivasan for…